Revenue increased 31.7%
Revenue changed +31.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +31.7% from the comparable as-filed period.
Operating income changed -351.9% from the comparable as-filed period.
Research & development changed +35.3% from the comparable as-filed period.
Net income changed -39.0% from the comparable as-filed period.
Operating margin changed -223 basis points from the comparable as-filed period.
Gross profit changed +34.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.